Clinical Trial Update: Ixazomib, Gemcitabine, and Doxorubicin in Treating Patients With Locally Advanced or Metastatic Kidney Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update evaluating ixazomib, gemcitabine, and doxorubicin in locally advanced or metastatic renal cell carcinoma, including renal medull…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma
• Renal Medullary Carcinoma

Drugs mentioned

• Doxorubicin (doxorubicin)
• Gemcitabine (Gemcitabine)
• NINLARO (ixazomib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Metastatic Kidney Medullary Carcinoma, Metastatic Renal Cell Carcinoma | Phase 2 | Status: ACTIVE_NOT_RECRUITING